The prevalence of bovine mastitis has been reduced over the past 25 years d
ue to the implementation of a five-point control plan aimed at reducing exp
osure, duration and transmission of intramammary infections by bacteria. Th
is has markedly reduced the incidence of bovine mastitis caused by bacteria
which show a contagious route of transmission, but has had little effect o
n the incidence of mastitis due to bacteria which infect the gland from an
environmental reservoir. Streptococcus uberis is one such bacterium which i
s responsible for a significant proportion of clinical mastitis worldwide.
The inadequacies of the current methods of mastitis control have led to the
search for additional measures, particularly vaccines to prevent intramamm
ary infection by this bacterium. Such an approach requires detailed knowled
ge of the pathogenesis of intramammary infection. Our understanding of this
area has grown in recent years but a lack of information still hampers dis
ease control. Both live vaccines and, recently, crude sub-unit vaccines hav
e shown promise against bovine mastitis due to S. uberis. Vaccines against
mastitis must, however, be able to control infection without the participat
ion of a marked inflammatory response. This review provides an overview of
the recent advances which have been made in our understanding of host-patho
gen interactions which promote infection and disease and highlights areas f
or strategic research aimed at controlling this bacterial infection.